(Q38207947)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777896%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

title

Effect of tumor cells and tumor microenvironment on NK-cell function (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777896%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777896%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Claudia Cantoni

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777896%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

author name string

Gabriella Pietra

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777896%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Maria Cristina Mingari

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777896%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Lorenzo Moretta

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777896%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

language of work or name

English

0 references

publication date

1 June 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777896%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

16 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777896%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777896%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777896%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

page(s)

1582-1592

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777896%20AND%20SRC:MED&resulttype=core&format=json

Receptors for HLA class-I molecules in human natural killer cells.

16 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Functions of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Early liaisons between cells of the innate immune system in inflamed peripheral tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Tumor immunoediting by NKp46.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Natural innate and adaptive immunity to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

The speed of change: towards a discontinuity theory of immunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificitie

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

p46, a novel natural killer cell-specific surface molecule that mediates cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Innate lymphoid cells--a proposal for uniform nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Nuclear factor-kappaB in cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Hypoxia--a key regulatory factor in tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

From sentinel cells to inflammatory culprits: cancer-associated fibroblasts in tumour-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Coordinated regulation of myeloid cells by tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Tumor-associated neutrophils: friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

The tumor microenvironment and its role in promoting tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Cancer despite immunosurveillance: immunoselection and immunosubversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

T-regulatory cells: key players in tumor immune escape and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

TLR activation of tumor-associated macrophages from ovarian cancer patients triggers cytolytic activity of NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Regulatory T cells control NK cells in an insulitic lesion by depriving them of IL-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Colorectal carcinoma-derived fibroblasts modulate natural killer cell phenotype and antitumor cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Immunobiology and conflicting roles of the human NKG2D lymphocyte receptor and its ligands in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Neuroblastoma-derived TGF-β1 modulates the chemokine receptor repertoire of human resting NK cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

RORγt⁺ innate lymphoid cells acquire a proinflammatory program upon engagement of the activating receptor NKp44.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Organ-specific features of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

TLR-dependent cross talk between human Kupffer cells and NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Decidual NK cells regulate key developmental processes at the human fetal-maternal interface.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

New views on natural killer cell-based immunotherapy for melanoma treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

The biology of human natural killer-cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

IL-18-primed helper NK cells collaborate with dendritic cells to promote recruitment of effector CD8+ T cells to the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Lenalidomide in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Dacarbazine-mediated upregulation of NKG2D ligands on tumor cells activates NK and CD8 T cells and restrains melanoma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

The activating receptor NKp46 is essential for the development of type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Natural cytotoxicity receptors NKp30, NKp44 and NKp46 bind to different heparan sulfate/heparin sequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Dendritic cells release HLA-B-associated transcript-3 positive exosomes to regulate natural killer function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Regulation of self-ligands for activating natural killer cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Identification of a cellular ligand for the natural cytotoxicity receptor NKp44.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Tumor cells of non-hematopoietic and hematopoietic origins express activation-induced C-type lectin, the ligand for killer cell lectin-like receptor F1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

CD48 as a novel molecular target for antibody therapy in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

The roles of TGFβ in the tumour microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

On the cytokines produced by human neutrophils in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Potent suppression of natural killer cell response mediated by the ovarian tumor marker CA125.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

The interaction between CD300a and phosphatidylserine inhibits tumor cell killing by NK cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

7 January 2021

Origin, phenotype and function of human natural killer cells in pregnancy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

7 January 2021

Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

7 January 2021

The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

7 January 2021

Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

7 January 2021

Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

7 January 2021

Natural killer cells are scarce in colorectal carcinoma tissue despite high levels of chemokines and cytokines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

7 January 2021

Dissecting CD56dim human NK cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

7 January 2021

Melanoma cells inhibit NK cell functions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

7 January 2021

Anticancer effects of imatinib via immunostimulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344272

7 January 2021

Identifiers

DOI

10.1002/EJI.201344272

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24777896%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

1 reference